These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 31633830)
41. Safety of anti-TNF therapy in inflammatory bowel disease during pregnancy. Khan N; Asim H; Lichtenstein GR Expert Opin Drug Saf; 2014 Dec; 13(12):1699-708. PubMed ID: 25406728 [TBL] [Abstract][Full Text] [Related]
42. Establishment of a measurement system to evaluate breast milk transfer of biological agents using dry filter paper: A multi-institutional study. Saito J; Yakuwa N; Hosokawa Y; Hamada H; Suzuki T; Sago H; Kaneko K; Yamatani A; Murashima A Br J Clin Pharmacol; 2024 Jan; 90(1):146-157. PubMed ID: 37548054 [TBL] [Abstract][Full Text] [Related]
43. Cost and effectiveness of biologics for rheumatoid arthritis in a commercially insured population. Curtis JR; Chastek B; Becker L; Quach C; Harrison DJ; Yun H; Joseph GJ; Collier DH J Manag Care Spec Pharm; 2015 Apr; 21(4):318-29. PubMed ID: 25803765 [TBL] [Abstract][Full Text] [Related]
44. Tocilizumab for coronavirus disease 2019 in pregnancy and lactation: a narrative review. Jorgensen SCJ; Lapinsky SE Clin Microbiol Infect; 2022 Jan; 28(1):51-57. PubMed ID: 34438068 [TBL] [Abstract][Full Text] [Related]
45. Safety of dermatologic medications in pregnancy and lactation: Part I. Pregnancy. Murase JE; Heller MM; Butler DC J Am Acad Dermatol; 2014 Mar; 70(3):401.e1-14; quiz 415. PubMed ID: 24528911 [TBL] [Abstract][Full Text] [Related]
46. A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview. Singh JA; Christensen R; Wells GA; Suarez-Almazor ME; Buchbinder R; Lopez-Olivo MA; Ghogomu ET; Tugwell P CMAJ; 2009 Nov; 181(11):787-96. PubMed ID: 19884297 [TBL] [Abstract][Full Text] [Related]
47. Fetal and Neonatal Adverse Drug Reactions Associated with Biologics Taken During Pregnancy by Women with Autoimmune Diseases: Insights from an Analysis of the World Health Organization Pharmacovigilance Database (VigiBase Dernoncourt A; Liabeuf S; Bennis Y; Masmoudi K; Bodeau S; Laville S; Hurtel-Lemaire AS; Gras-Champel V; Batteux B BioDrugs; 2023 Jan; 37(1):73-87. PubMed ID: 36401769 [TBL] [Abstract][Full Text] [Related]
48. Safety of New Biologics (Vedolizumab and Ustekinumab) and Small Molecules (Tofacitinib) During Pregnancy: A Review. Gisbert JP; Chaparro M Drugs; 2020 Jul; 80(11):1085-1100. PubMed ID: 32562207 [TBL] [Abstract][Full Text] [Related]
49. Registries in European post-marketing surveillance: a retrospective analysis of centrally approved products, 2005-2013. Bouvy JC; Blake K; Slattery J; De Bruin ML; Arlett P; Kurz X Pharmacoepidemiol Drug Saf; 2017 Dec; 26(12):1442-1450. PubMed ID: 28345151 [TBL] [Abstract][Full Text] [Related]
50. Ethics and the marketing authorization of pharmaceuticals: what happens to ethical issues discovered post-trial and pre-marketing authorization? Bernabe RDLC; van Thiel GJMW; Breekveldt NS; Gispen CC; van Delden JJM BMC Med Ethics; 2020 Oct; 21(1):103. PubMed ID: 33109181 [TBL] [Abstract][Full Text] [Related]
51. The use of biologic agents in pregnancy and breastfeeding. Horst S; Kane S Gastroenterol Clin North Am; 2014 Sep; 43(3):495-508. PubMed ID: 25110255 [TBL] [Abstract][Full Text] [Related]
52. Intrauterine Exposure to Biologics in Inflammatory Autoimmune Diseases: A Systematic Review. Ghalandari N; Dolhain RJEM; Hazes JMW; van Puijenbroek EP; Kapur M; Crijns HJMJ Drugs; 2020 Nov; 80(16):1699-1722. PubMed ID: 32852745 [TBL] [Abstract][Full Text] [Related]
53. Effect of antenatal milk expression education on lactation outcomes in birthing people with pre-pregnancy body mass index ≥25: protocol for a randomized, controlled trial. Demirci JR; Glasser M; Bogen DL; Sereika SM; Ren D; Ray K; Bodnar LM; O'Sullivan TA; Himes K Int Breastfeed J; 2023 Mar; 18(1):16. PubMed ID: 36927811 [TBL] [Abstract][Full Text] [Related]
54. Systematic review on the safety of methotrexate in rheumatoid arthritis regarding the reproductive system (fertility, pregnancy, and breastfeeding). Martínez Lopez JA; Loza E; Carmona L Clin Exp Rheumatol; 2009; 27(4):678-84. PubMed ID: 19772806 [TBL] [Abstract][Full Text] [Related]
55. Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis: a systematic review and economic evaluation. Rodgers M; Epstein D; Bojke L; Yang H; Craig D; Fonseca T; Myers L; Bruce I; Chalmers R; Bujkiewicz S; Lai M; Cooper N; Abrams K; Spiegelhalter D; Sutton A; Sculpher M; Woolacott N Health Technol Assess; 2011 Feb; 15(10):i-xxi, 1-329. PubMed ID: 21333232 [TBL] [Abstract][Full Text] [Related]
56. The use of biological drugs in psoriasis patients prior to pregnancy, during pregnancy and lactation: a review of current clinical guidelines. Owczarek W; Walecka I; Lesiak A; Czajkowski R; Reich A; Zerda I; Narbutt J Postepy Dermatol Alergol; 2020 Dec; 37(6):821-830. PubMed ID: 33603597 [TBL] [Abstract][Full Text] [Related]
57. Safety and efficacy of immunomodulators and biologics during pregnancy and lactation for the treatment of inflammatory bowel disease. Saha S; Wald A Expert Opin Drug Saf; 2012 Nov; 11(6):947-57. PubMed ID: 22954378 [TBL] [Abstract][Full Text] [Related]
58. Antirheumatic medications in pregnancy and breastfeeding. Birru Talabi M; Clowse MEB Curr Opin Rheumatol; 2020 May; 32(3):238-246. PubMed ID: 32205567 [TBL] [Abstract][Full Text] [Related]
59. Evaluation of Drug Labels Following the 2015 Pregnancy and Lactation Labeling Rule. Byrne JJ; Saucedo AM; Spong CY JAMA Netw Open; 2020 Aug; 3(8):e2015094. PubMed ID: 32865574 [TBL] [Abstract][Full Text] [Related]